Cardiovascular Drug Market Report

Global and Region Cardiovascular Drug Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：186
  • REPORT CODE：GMM918491
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Cardiovascular Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Cardiovascular Drugmarket, defines the market attractiveness level of Cardiovascular Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Cardiovascular Drug industry, describes the types of Cardiovascular Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cardiovascular Drug market and the development prospects and opportunities of Cardiovascular Drug industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cardiovascular Drug market in Chapter 13.

    By Player:

    • Janssen Pharmaceuticals, Inc

    • Gilead Sciences, Inc

    • Novartis AG

    • Pfizer Inc

    • F Hoffmann-La Roche Ltd

    • Bristol-Myers Squibb Company

    • AstraZeneca

    • Bayer AG

    • Merck & Co, Inc

    • Sanofi

    By Type:

    • Antihypertensive

    • Antihyperlipidemic

    • Anticoagulants

    • Antiplatelet Drugs

    • Others

    By End-User:

    • Hypertension

    • Hyperlipidemia

    • Coronary Artery Disease

    • Arrhythmia

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Cardiovascular Drug Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Cardiovascular Drug Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Cardiovascular Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Cardiovascular Drug Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Cardiovascular Drug Market Analysis and Outlook to 2022

    • 7.1 Global Cardiovascular Drug Consumption (2017-2022)

    • 7.2 United States Cardiovascular Drug Consumption (2017-2022)

    • 7.3 Europe Cardiovascular Drug Consumption (2017-2022)

    • 7.4 China Cardiovascular Drug Consumption (2017-2022)

    • 7.5 Japan Cardiovascular Drug Consumption (2017-2022)

    • 7.6 India Cardiovascular Drug Consumption (2017-2022)

    • 7.7 South Korea Cardiovascular Drug Consumption (2017-2022)

    8 Region and Country-wise Cardiovascular Drug Market Analysis and Outlook to 2028

    • 8.1 Global Cardiovascular Drug Consumption Forecast (2022-2028)

    • 8.2 United States Cardiovascular Drug Consumption Forecast (2022-2028)

    • 8.3 Europe Cardiovascular Drug Consumption Forecast (2022-2028)

    • 8.4 China Cardiovascular Drug Consumption Forecast (2022-2028)

    • 8.5 Japan Cardiovascular Drug Consumption Forecast (2022-2028)

    • 8.6 India Cardiovascular Drug Consumption Forecast (2022-2028)

    • 8.7 South Korea Cardiovascular Drug Consumption Forecast (2022-2028)

    9 Global Cardiovascular Drug Market Outlook by Types and Applications to 2022

    • 9.1 Global Cardiovascular Drug Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Antihypertensive Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Antihyperlipidemic Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Anticoagulants Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Antiplatelet Drugs Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Cardiovascular Drug Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Hyperlipidemia Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Coronary Artery Disease Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Arrhythmia Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Cardiovascular Drug Market Outlook by Types and Applications to 2028

    • 10.1 Global Cardiovascular Drug Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Antihypertensive Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Antihyperlipidemic Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Anticoagulants Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Antiplatelet Drugs Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Cardiovascular Drug Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Hyperlipidemia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Coronary Artery Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Arrhythmia Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Cardiovascular Drug Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Cardiovascular Drug Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Cardiovascular Drug Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Cardiovascular Drug Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Cardiovascular Drug Market Competitive Analysis

    • 14.1 Janssen Pharmaceuticals, Inc

      • 14.1.1 Janssen Pharmaceuticals, Inc Company Details

      • 14.1.2 Janssen Pharmaceuticals, Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Janssen Pharmaceuticals, Inc Cardiovascular Drug Product and Service

    • 14.2 Gilead Sciences, Inc

      • 14.2.1 Gilead Sciences, Inc Company Details

      • 14.2.2 Gilead Sciences, Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Gilead Sciences, Inc Cardiovascular Drug Product and Service

    • 14.3 Novartis AG

      • 14.3.1 Novartis AG Company Details

      • 14.3.2 Novartis AG Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Novartis AG Cardiovascular Drug Product and Service

    • 14.4 Pfizer Inc

      • 14.4.1 Pfizer Inc Company Details

      • 14.4.2 Pfizer Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Pfizer Inc Cardiovascular Drug Product and Service

    • 14.5 F Hoffmann-La Roche Ltd

      • 14.5.1 F Hoffmann-La Roche Ltd Company Details

      • 14.5.2 F Hoffmann-La Roche Ltd Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 F Hoffmann-La Roche Ltd Cardiovascular Drug Product and Service

    • 14.6 Bristol-Myers Squibb Company

      • 14.6.1 Bristol-Myers Squibb Company Company Details

      • 14.6.2 Bristol-Myers Squibb Company Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Bristol-Myers Squibb Company Cardiovascular Drug Product and Service

    • 14.7 AstraZeneca

      • 14.7.1 AstraZeneca Company Details

      • 14.7.2 AstraZeneca Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 AstraZeneca Cardiovascular Drug Product and Service

    • 14.8 Bayer AG

      • 14.8.1 Bayer AG Company Details

      • 14.8.2 Bayer AG Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bayer AG Cardiovascular Drug Product and Service

    • 14.9 Merck & Co, Inc

      • 14.9.1 Merck & Co, Inc Company Details

      • 14.9.2 Merck & Co, Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Merck & Co, Inc Cardiovascular Drug Product and Service

    • 14.10 Sanofi

      • 14.10.1 Sanofi Company Details

      • 14.10.2 Sanofi Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Sanofi Cardiovascular Drug Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Cardiovascular Drug

    • Figure Cardiovascular Drug Picture

    • Table Global Cardiovascular Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cardiovascular Drug Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Cardiovascular Drug Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Cardiovascular Drug Consumption by Country (2017-2022)

    • Figure United States Cardiovascular Drug Consumption and Growth Rate (2017-2022)

    • Table Europe Cardiovascular Drug Consumption and Growth Rate (2017-2022)

    • Figure China Cardiovascular Drug Consumption and Growth Rate (2017-2022)

    • Figure Japan Cardiovascular Drug Consumption and Growth Rate (2017-2022)

    • Figure India Cardiovascular Drug Consumption and Growth Rate (2017-2022)

    • Figure South Korea Cardiovascular Drug Consumption and Growth Rate (2017-2022)

    • Figure Global Cardiovascular Drug Consumption Forecast by Country (2022-2028)

    • Figure United States Cardiovascular Drug Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Cardiovascular Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Cardiovascular Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Cardiovascular Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Cardiovascular Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Cardiovascular Drug Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihypertensive Consumption and Growth Rate (2017-2022)

    • Figure Global Antihyperlipidemic Consumption and Growth Rate (2017-2022)

    • Figure Global Anticoagulants Consumption and Growth Rate (2017-2022)

    • Figure Global Antiplatelet Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Hyperlipidemia Consumption and Growth Rate (2017-2022)

    • Figure Global Coronary Artery Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Arrhythmia Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Antihypertensive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antihyperlipidemic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Anticoagulants Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Antiplatelet Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hyperlipidemia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coronary Artery Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Arrhythmia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Cardiovascular Drug Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Cardiovascular Drug Export by Region (Top 5 Countries) (2017-2028)

    • Table Janssen Pharmaceuticals, Inc (Foundation Year, Company Profile and etc.)

    • Table Janssen Pharmaceuticals, Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Janssen Pharmaceuticals, Inc Cardiovascular Drug Product and Service

    • Table Gilead Sciences, Inc (Foundation Year, Company Profile and etc.)

    • Table Gilead Sciences, Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences, Inc Cardiovascular Drug Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Cardiovascular Drug Product and Service

    • Table Pfizer Inc (Foundation Year, Company Profile and etc.)

    • Table Pfizer Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Cardiovascular Drug Product and Service

    • Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)

    • Table F Hoffmann-La Roche Ltd Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table F Hoffmann-La Roche Ltd Cardiovascular Drug Product and Service

    • Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Company Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Company Cardiovascular Drug Product and Service

    • Table AstraZeneca (Foundation Year, Company Profile and etc.)

    • Table AstraZeneca Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Cardiovascular Drug Product and Service

    • Table Bayer AG (Foundation Year, Company Profile and etc.)

    • Table Bayer AG Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer AG Cardiovascular Drug Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Cardiovascular Drug Product and Service

    • Table Sanofi (Foundation Year, Company Profile and etc.)

    • Table Sanofi Cardiovascular Drug Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi Cardiovascular Drug Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US